The Patent Finder

Amura Therapeutics Limited

Also on record
Records under this name other than patents Amura Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Amura Therapeutics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,425,562Inhibitors of cruzipain and other cysteine proteases
Formerly held
Lapsed on the fee record
Ended Sep 16, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 16, 2020USPTO record
US 8,053,437Furo[3. 2-B] pyrrol derivatives
Lapsed on the fee record
Ended Nov 8, 2019 · USPTO record
Lapsed on the fee recordEnded Nov 8, 2019USPTO record
US 8,039,641Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates
Formerly held
Lapsed on the fee record
Ended Oct 18, 2019 · USPTO record
Lapsed on the fee recordEnded Oct 18, 2019USPTO record
US 8,008,290Compounds
Formerly held
Lapsed on the fee record
Ended Aug 30, 2019 · USPTO record
Lapsed on the fee recordEnded Aug 30, 2019USPTO record
US 9,045,492Piperazine compounds
Formerly held
Lapsed on the fee record
Ended Jun 2, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 2, 2019USPTO record
US 8,933,109Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors
Lapsed on the fee record
Ended Jan 13, 2019 · USPTO record
Lapsed on the fee recordEnded Jan 13, 2019USPTO record
US 7,132,449Inhibitors of cruzipain and other cysteine proteases
Lapsed on the fee record
Ended Nov 7, 2018 · USPTO record
Lapsed on the fee recordEnded Nov 7, 2018USPTO record
US 8,877,927Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors
Formerly held
Lapsed on the fee record
Ended Nov 4, 2018 · USPTO record
Lapsed on the fee recordEnded Nov 4, 2018USPTO record
US 7,803,803Tetrahydrofuro[3,2-B] pyrrol-3-ones as cathepsin K inhibitors
Lapsed on the fee record
Ended Sep 28, 2018 · USPTO record
Lapsed on the fee recordEnded Sep 28, 2018USPTO record
US 7,799,791Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases
Lapsed on the fee record
Ended Sep 21, 2018 · USPTO record
Lapsed on the fee recordEnded Sep 21, 2018USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited